Related Experiment Videos
Prevention of intraventricular haemorrhage by fresh frozen plasma
Insights
Fresh frozen plasma may prevent intraventricular hemorrhage in preterm infants. This study found a significant reduction in brain bleeds among infants receiving fresh frozen plasma compared to controls.
Area of Science:
- Neonatalogy
- Pediatric Medicine
- Hematology
Background:
- Intraventricular hemorrhage (IVH) is a serious complication in preterm infants.
- Premature infants are at high risk for bleeding events due to immature coagulation systems.
Purpose of the Study:
- To evaluate the efficacy of fresh frozen plasma (FFP) in preventing intraventricular hemorrhage in very preterm infants.
- To assess the impact of FFP on coagulation factors in this vulnerable population.
Main Methods:
- A randomized controlled trial was conducted with 73 preterm infants (<1500 g or <32 weeks' gestation).
- Infants were randomly assigned to receive either FFP (10 ml/kg at admission and 24 hours) or a control.
- Coagulation factors were measured at birth and 48 hours of age.
Main Results:
- A significantly lower incidence of intraventricular hemorrhage was observed in the FFP treatment group (14%) compared to the control group (41%) (P = 0.022).
- No significant differences in coagulation factors were found between the groups at any time point.
- The incidence of IVH was reduced from 41% in controls to 14% in the FFP group.
Conclusions:
- Fresh frozen plasma administration appears to be beneficial in preventing intraventricular hemorrhage in preterm infants.
- FFP may offer a protective effect against IVH, independent of changes in measured coagulation factors.
- Further research may explore the precise mechanisms behind FFP's protective role in IVH prevention.
Abstract:
Seventy three preterm infants weighing less than 1500 g or less than 32 weeks' gestation, or both, were allocated randomly to treatment (fresh frozen plasma 10 ml/kg on admission and at 24 hours of age) or control groups. Fifteen (41%) out of 37 control patients sustained intraventricular haemorrhage compared with five (14%) of 36 patients receiving treatment (X2 = 5.24, P = 0.022). No difference was found in coagulation factors measured at birth or at 48 hours of age in both groups. Fresh frozen plasma appears to have a beneficial effect in the prevention of intraventricular haemorrhage.